4,068 posters, 219 videos, 101 topics, 69 sessions, 14,365 authors, 6,128 institutions
ePostersLive by SciGen Technologies S.A. All rights reserved.
Alzheimer's Association International Conference 2026
July 12-15, 2026 | London, United Kingdom, and Online
8591
Safety And Usability Of Novel Repetitive Transcranial Magnetic Stimulation In Alzheimer And Mild Cognitive Impairment
Poster Presenter
Authors
Part of Topic
Safety And Usability Of Novel Repetitive Transcranial Magnetic Stimulation In Alzheimer's disease And Mild Cognitive Impairment
Novel BrainStim-100 rTMS showed no serious adverse events occurred during 48 person-weeks of treatment.
Treatment adherence was 100%, with no safety-related dropouts.
Participants rated the device as easy to use and comfortable.
Comments
Email is required but is not shown publicly.
Loading comments...